TrialBMC cancer2020

High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08.

Martin Fehr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.